Pertuzumab Plus Trastuzumab in Patients With Endometrial Cancer With ERBB2/3 Amplification, Overexpression, or Mutation: Results From the TAPUR Study.
Eugene R AhnMichael RothePam K MangatElizabeth Garrett-MayerHussein M Ali-AhmadJohn K ChanMichael L MaitlandSapna R PatelZachary ReeseAni S BalmanoukianCharles W DrescherRui LiApostolia-Maria TsimberidouCharles A LeathRaegan O'LoneGina N GranthamSusan HalabiRichard L SchilskyPublished in: JCO precision oncology (2023)
amplification and warrants additional study.